AUSSIE DMT BAN
Related Articles
- Australian TGA warns of exenatide-induced pancreatitis. // Reactions Weekly;6/5/2010, Issue 1304, p2
The article deals with the public advisory issued by the Australian Therapeutic Goods Administration (TGA) in June 2010 regarding exenatide-induced pancreatitis.
- TGA advises of dosing change for citalopram. // Reactions Weekly;11/12/2011, Issue 1377, p3
The article reports on the recommendation by the Australian Therapeutic Goods Administration (TGA) that citalopram no longer be administered at dosages of less than 40 milligrams (mg)/day.
- Australian TGA updates safety info for varenicline. // Reactions Weekly;8/7/2010, Issue 1313, p6
The article reports on an update issued by the Australian Therapeutic Goods Administration (TGA) on the safety of varenicline (Champix), including its associated psychiatric side effects.
- Combination antihypertensive approved. // Australian Journal of Pharmacy;Apr2011, Vol. 92 Issue 1091, p52
The article offers information on the approval of the fixed-dose combination therapy, Twynsta, by the Therapeutic Goods Administration (TGA) in Australia.
- Australia's TGA and NZ's Medsafe to merge. // PharmacoEconomics & Outcomes News;6/25/2011, Issue 631, p9
The article discusses the merging of Australia's Therapeutic Goods Administration (TGA) and New Zealand's Medsafe into a joint scheme to be named the Australia New Zealand Therapeutic Products Agency (ANZTPA) to regulate therapeutic goods and provide health benefits for consumers, reduce...
- IVD Australia sees new regs as more expensive than forecast. // Medical Device Daily;3/31/2010, Vol. 14 Issue 61, p1
This article announces the plan of Australia's Therapeutic Goods Administration (TGA) to start transitioning its regulatory structure for in vitro diagnostics in July 2010.
- TGA on board with single-audit program. McCARTY, MARK // Medical Device Daily;12/5/2012, Vol. 16 Issue 235, p6
The article reports on the participation of Australia's Therapeutic Goods Administration in the medical device single audit program MDSAP.
- TGA approves PoC for AIDS virus. McCarty, Mark // Medical Device Daily;12/18/2012, Vol. 16 Issue 244, p6
The article reports that Determine HIV, a point-of-care test for the AIDS virus, has been approved by the Therapeutic Goods Administration (TGA) of Australia.
- TGA: problems with meshes 'about the use.'. // Medical Device Daily;10/30/2012, Vol. 16 Issue 210, p8
The article deals with the October 15, 2012 statement issued by Australia's Therapeutic Goods Administration about adverse events associated with surgical meshes.
